Reckitt Benckiser Group plc (RBGLY)
| Market Cap | 41.54B |
| Revenue (ttm) | 18.11B |
| Net Income (ttm) | 1.95B |
| Shares Out | n/a |
| EPS (ttm) | 2.73 |
| PE Ratio | 21.29 |
| Forward PE | n/a |
| Dividend | 0.47 (3.86%) |
| Ex-Dividend Date | Aug 5, 2024 |
| Volume | 242,700 |
| Open | 11.93 |
| Previous Close | 12.04 |
| Day's Range | 11.93 - 12.14 |
| 52-Week Range | 10.24 - 15.03 |
| Beta | 0.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 6, 2025 |
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet bra... [Read more]
Financial Performance
In 2023, Reckitt Benckiser Group's revenue was 14.61 billion, an increase of 1.07% compared to the previous year's 14.45 billion. Earnings were 1.64 billion, a decrease of -29.48%.
Financial numbers in GBP Financial StatementsNews
Reckitt Benckiser: Still Cheap On Nutrition Woes
Reckitt Benckiser shareholders facing challenges due to litigation costs, but stock trading below average with solid underlying business. Read why RBGLY is a Buy.
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into Reckitt Benckiser Group PLC (OTC: RBGLY)
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Reckitt Benckiser Group PLC (“Reckitt” or the “...
Advent, Apollo among potential bidders for Reckitt's homecare assets, Bloomberg News reports
Private equity groups Advent International and Apollo Global are among firms mulling a potential buyout of British consumer goods company Reckitt's homecare assets, Bloomberg News reported on Wednesda...
Buyout Firms Said to Circle Reckitt’s £6 Billion Homecare Assets
Advent International and Apollo Global Management Inc. are among buyout firms studying a potential acquisition of Reckitt Benckiser Group Plc’s homecare assets, according to people familiar with the m...
Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win
Shares of Abbott Laboratories (ABT) are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a jury cleared the two infant formula makers of liability for a boy's de...
Reckitt Shares Surge After Baby Formula Lawsuit Win
Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.
Reckitt Shares Surge After Baby Formula Lawsuit Win
Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.
Abbott Labs and Reckitt Benckiser shares surge on court’s baby formula ruling
A court in St. Louis, Missouri ruled in favor of Abbott Laboratories and Reckitt Benckiser over claims their specialized baby formula caused users to develop a bowel disease called NEC
Reckitt Surges Most in 24 Years After Baby Formula Trial Win
Shares of Reckitt Benckiser Group Plc jumped in the wake of a US jury verdict that cleared it and Abbott Laboratories over claims they hid potential risks of their premature-infant formulas.
Reckitt Benckiser up 10% after being cleared of liability in preterm formula case
Shares in British consumer goods company Reckitt Benckiser jumped over 10% on Friday after the company, along with U.S.-based Abbott Labs, was cleared of liability in a preterm formula case.
Abbott, Reckitt Score First Victory in Baby Formula Trial
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby ...
Abbott, Reckitt cleared of liability in latest preterm formula case
Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of their premature ba...
Abbott jumps as jury says company, Reckitt not liable in infant formula case
Financial writer covers Abbot's 4.3% rise after being found not liable in baby formula lawsuit, along with Reckitt Benckiser.
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead
A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for ...
Reckitt Benckiser Group plc (RBGPF) Q3 2024 Earnings Call Transcript
Lysol Maker Reckitt Benckiser Beats Views as Easing Prices Draw Shoppers
Lysol maker Reckitt Benckiser’s revenue fell by less than expected in the third quarter as declines in sales volumes eased, and confirmed its targets for the full year.
Lysol Maker Reckitt Benckiser Beats Views as Easing Prices Draw Shoppers
Lysol maker Reckitt Benckiser's revenue fell by less than expected in the third quarter as declines in sales volumes eased, and confirmed its targets for the full year.
Reckitt Limits Sales Decline Amid US Baby Formula Lawsuits
Reckitt Benckiser Plc sales fell less than expected, offering limited relief for investors concerned about US lawsuits over its formula for premature babies.
Healthcare helps Reckitt beat quarterly sales estimates
Reckitt reported a smaller than expected fall in third-quarter underlying sales on Wednesday, helped by its health business, which makes Nurofen painkillers and Strepsils lozenges.
Three Quick Facts: Lloyds, Reckitt Benckiser, WPP
Lloyds impairments down & interest income stable, hit to Reckitt's nutrition sales less than expected, WPP notes gains in Q3
Reckitt Benckiser Is Still A 'Hold' Despite The New Strategy
Reckitt Benckiser reports mixed half-year results, with slight revenue growth and improved cash flow. New growth strategy in place. Read more here.
Abbott, Reckitt face trial over premature baby formula amid alarm from doctors
A Missouri mother and her lawyers this week will aim to convince a jury that Abbott , Reckitt's Mead Johnson and St. Louis Children's Hospital are responsible for a severe intestinal illness that she ...
Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula
European consumer giant Reckitt Benckiser Group Plc (OTC: RBGLY) (OTC: RBGPF) has reportedly kickstarted preliminary talks with potential buyers regarding the sale of its homecare division, which fe...
Reckitt Benckiser starts discussions on sale of Mead Johnson, Lysol assets - report
Reckitt initiates discussions on $7.9 billion homecare assets sale, Bloomberg reports
Reckitt Benckiser has initiated early discussions with potential suitors for a sale of its homecare assets, which could be worth over 6 billion pounds ($7.89 billion), Bloomberg News reported on Tuesd...